Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosisRachael I. Scahill, Sarah J. Tabrizi, Mena Farag et al.|Nature Medicine|2025Cited by 53
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkersSophia Weiner, Johan Gobom, Mathias Sauer et al.|Clinical Proteomics|2022Cited by 30
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalusSophia Weiner, Johan Gobom, Antti Junkkari et al.|Fluids and Barriers of the CNS|2023Cited by 18
Plasma tau biomarkers for biological staging of Alzheimer’s diseaseLaia Montoliu‐Gaya, Oskar Hansson, Nicholas J. Ashton et al.|Nature Aging|2025Cited by 17
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypesAitana Sogorb‐Esteve, Stefano Gazzina, Sophia Weiner et al.|Science Translational Medicine|2025Cited by 13